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INTRODUCTION 
 Tuberculosis is a specific infectious disease caused by 
mycobacterium tuberculosis.  The disease primarily affects lungs 
and causes pulmonary tuberculosis. 
 Tuberculosis remains a world wide public health problem 
despite the fact that the causative organism was discovered more 
than 100 years ago. It is estimated that about 1/3 rd of current 
global population is infected asymptomatically with tuberculosis 
of whom  5-10 percent will develop clinical disease during their 
life time.  Most new cases and deaths occur in developing 
countries where infection is often acquired in childhood. 
Comparing different parts of the world the African region (24%). 
South east Asia region (35%) and Western Pacific region (24%) 
together accounted for 83% of all notified new and relapse cases.3 
 India is the highest TB burden country in the world and 
accounts for nearly one fifth (20%) of global burden of 
tuberculosis.  Every year approximately 1.8 million persons 
develop tuberculosis of which about 0.8 million are new smear 
positive highly infectious cases. 
 World wide the number of people infected with both HIV 
and tuberculosis is rising.  The HIV virus damages the body 
natural defenses – the immune system – and accelerates the speed 
at which TB progresses from a harmless infection to a life 
threatening condition.  TB has already become the most frequent 
opportunistic infection that kills HIV positive people.  The 
diagnosis of tuberculosis in individual patients using the standard 
diagnostic tools can be more difficult if they have advanced HIV 
infection. 
 HIV and tuberculosis interact in several ways  
1. Reactivation of latent infection : People who are infected 
with both tuberculosis and HIV are 25-30 times more 
likely to develop tuberculosis.  This is because HIV stops 
the immune system working effectively and tuberculosis 
bacilli are able to multiply rapidly.  In developing 
countries HIV associated tubercular disease is very 
common. 
 
2. Primary infection :  New tubercular infection in people 
with HIV can progress to active disease very quickly. In 
the USA active tubercular disease in two thirds of people 
with both infections is due to recent infection rather than 
reactivation of latent infection.  People with HIV are at 
risk of being newly infected, if they are exposed to 
tuberculosis because their weakened immune system 
makes them more vulnerable. 
 
3. Recurring Infection :  People with HV who have been 
cured of tuberculosis infection may be more at risk of 
developing tuberculosis again.  However it is not clear 
whether this is because of reinfection or relapse. 
 
4. In the community :  There are more new cases of active 
tuberculosis because more people infected with 
tuberculosis develop active disease, and those newly 
infected become ill faster.  This means that there are 
more people in the community who are infectious to 
others.  Larger number of people with active disease 
mean more people will die from tuberculosis unless they 
are treated.  The association of tuberculosis with HIV 
means that people suffer additional discrimination.  
Community education is needed to increase awareness 
that tuberculosis is curable and most important, that 
people are no longer infectious after the first few weeks 
of treatment. 
In most people in the early stages of HIV infection, 
symptoms of tuberculosis are similar as in people without HIV 
infection.  In areas where many people have HIV infection, 
tuberculosis programmes should continue to focus on 
identifying infectious sputum-smear-positive cases through 
microscopy.  However, diagnosis of tuberculosis in individual 
patients using the standard diagnostic tools can be more 
difficult if they have advanced HIV infection because : 
a) HIV positive people with pulmonary tuberculosis may have 
a higher frequency of negative sputum smears. Confirming 
the diagnosis may require sputum culture. 
 
b) The tuberculosis skin test often fails to work in people who 
are HIV positive because it relies on measuring the 
response of a person’s immune system.  If the immune 
system has been damaged by HIV, it may not respond even 
though the person is infected with tuberculosis.  HIV 
positive people with tuberculosis, therefore have a higher 
frequency of false negative tuberculin skin test results. 
 
c) Cases of extra pulmonary tuberculosis seem to be more 
common in people who are co-infected. 
d) Chest radiography may be less useful in people with HIV 
because they have less cavitation.  Cavities usually develp 
because the immune response to the tubercular bacilli leads 
to some destruction of lung tissue.  In people with HIV, 
who do not have a fully functioning immune system, there 
is less tissue destruction and hence less lung cavitation. 
 
The radiological manifestations of tuberculosis in HIV 
infected patients may vary according to the degree of immuno 
suppression. 
 
 
 
 
 
 
 
 
  
 
AIM OF THE STUDY 
 
¾ To compare the chest X ray features of HIV positive 
pulmonary tuberculosis patients with HIV negative 
pulmonary tuberculosis patients. 
¾ To determine the percentage of patients with atypical chest 
x ray in HIV positive and negative groups 
¾ To determine the relationship between atypical chest x rays 
and CD4 count. 
 
 
 
 
 
 
REVIEW OF LITERATURE 
Tuberculosis: 
 Tuberculosis, one of the oldest diseases known to affect 
humans, is a major cause of death worldwide. If properly treated, 
tuberculosis caused by drug-susceptible strains is curable in 
virtually all case. If untreated, the disease may be fatal within 5 
years in 50-65% of cases. Transmission usually takes place 
through the airborne spread of droplet nuclei produced by 
patients with infectious pulmonary tuberculosis. Mycobacteria 
belong to the family Mycobacteriaceae and the order 
actinomycetales. 
M.Tuberculosis is a rod-shaped, non-spore-forming, thin 
aerobic bacterium measuring 0.5µm by 3µm. Mycobacteria, 
including M.tuberculosis, are often neutral on Gram’s staining. 
However, once stained, the bacilli cannot be decolorized by acid 
alcohol; this characteristic justifies their classification as acid-fast 
bacilli. Acid fastness is due mainly to the organisms’ high content 
of mycolic acids, long-chain cross-linked fatty acids, and other 
cell-wall lipids.  
More than 5 million new cases of tuberculosis (all forms, 
both pulmonary and extrapulmonary) were reported to the World 
Health Organization (WHO) in 2005;>90% of cases were 
reported from developing countries. 1  
Recent data on trends indicate that in 2005 tuberculosis 
incidence was stable or falling in most regions; the result is a 
small decline globally from figures in previous years. This global 
reduction is due largely to an apparent peaking in sub-Saharan 
Africa, where incidence had risen steeply since the 1980s as a 
result of the HIV epidemic and the paucity of the health services. 
In eastern Europe, incidence increased during the 1990s because 
of deterioration in socioeconomic conditions and the health care 
infrastructure; however, after peaking in 2001, incidence has 
recently stabilized. 
 
 
From exposure to infection:- 
 M.Tuberculosis is most commonly transmitted from a 
person with infectious pulmonary tuberculosis to others by 
droplet nuclei, which are aerosolized by coughing, sneezing, or 
speaking. There may be as many as 3000 infectious nuclei per 
cough. 1 
The most infectious patients have cavitary pulmonary 
disease or much less commonly, laryngeal tuberculosis and 
produce sputum containing as many as 105-107 AFB/mL. Patients 
with sputum smear-negative/culture-positive tuberculosis are less 
infectious, and those with culture-negative pulmonary disease 
and extrapulmonary tuberculosis are essentially noninfectious. 
Because persons with both HIV infection and tuberculosis are 
less likely to have cavitations, they may be less infectious than 
persons without HIV co-infection.  
From infection to disease:- 
 Unlike the risk of acquiring infection with M.Tuberculosis, 
the risk of developing disease after being infected depends 
largely on endogenous factors, such as the individual’s innate 
immunologic and nonimmunologic defenses and level of function 
of cell mediated immunity (CMI). Clinical illness directly 
following infection is classified as primary tuberculosis and is 
common among children up to 4 years of age and among 
immunocompromised persons. Although primary tuberculosis 
may be severe and disseminated , it is not generally associated 
with high-level transmissibility. When infection is a acquired 
later in life, the chance is greater that the mature immune system 
will contain it at least temporarily. The majority of infected 
individuals who ultimately develop tuberculosis do so within the 
first year or two after infection. Dormant bacilli, however, may 
persist for years before reactivating to produce secondary (or 
postprimary) tuberculosis, which, because of frequent cavitation, 
is more often infectious than is primary disease. Overall, it is 
estimated that upto 10% of infected persons will eventually 
develop active tuberculosis in their lifetime. The risk is much 
higher among HIV-infected persons. Among infected persons, the 
incidence of tuberculosis is highest during late adolescene and 
early adulthood; the reasons are unclear. 
Natural history of disease:- 
 Studies conducted in various countries before the advent of 
chemotherapy showed that untreated tuberculosis is often fatal. 
About one-third of patients died within 1 year after diagnosis, and 
one-half died within 5 years. The 5 year mortality rate among 
sputum smear-positive cases was 65%. Of the survivors at 5 
years, ~60% had undergone spontaneous remission, while the 
remainder were still excreting tubercle bacilli. 1,3 
Clinical Manifestations:- 
 Tuberculosis is classified as pulmonary, extrapulmonary, or 
both. Before the advent of HIV infection, ~80% of all new cases 
of tuberculosis were limited to the lungs.However, upto two-
thirds of HIV-infected patients with tuberculosis may have both 
pulmonary and extrapulmonary disease or extrapulmonary 
disease alone. 
 
Primary disease:-  
 Primary pulmonary tuberculosis occurs soon after the initial 
infection with tubercle bacilli. In areas of high tuberculosis 
transmission, this form of disease is often seen in children. 
Because most inspired air is distributed to the middle and lower 
lung zones, these areas of the lungs are most commonly involved 
in primary tuberculosis. The lesion forming after infection is 
usually peripheral and accompanied in more than half of cases by 
hilar or paratracheal lymphadenopathy, which may not be 
detectable on chest radiography. In the majority of cases, the 
lesion heals spontaneously and may later be evident as a small 
calcified nodule. (Ghon lesion) 
Postprimary disease:- 
 Also called adult-type, reactivation, or secondary 
tuberculosis, postprimary disease results from endogenous 
reactivation of latent infection and is usually localized to the 
apical and posterior segments of the upper lobes, where the 
substantially higher mean oxygen tension (compared with that in 
the lower zones) favours mycobacterial growth, In addition, the 
superior segments of the lower lobes are frequently involved. The 
extent of lung parenchymal involvement varies greatly, from 
small infiltrates to extensive cavitary disease. With cavity 
formation, liquefied necrotic contents are ultimately discharged 
into the airways, resulting in satellite lesions within the lungs that 
may in turn undergo cavitation.  Massive involvement of 
pulmonary segments or lobes, with coalescence of lesions, 
produces tuberculous pneumonia. While up to one-third of 
untreated patients reportedly succumb to severe pulmonary 
tuberculosis within a few weeks or months after onset (the 
classical “galloping consumption” of the past), others undergo a 
process of spontaneous remission or proceed along a chronic, 
progressively debilitating course (“consumption”). Under  these 
circumstances, some pulmonary lesions become fibrotic and may 
later calcify, but cavities persist in other parts of the lungs.  
Early in the course of disease, symptoms and signs are often 
non-specific and insidious, consisting mainly of fever and night 
sweats, weight loss, anorexia, general malaise, and weakness. 
However in the majority of cases, cough eventually develops-
often initially nonproductive and subsequently accompanied by 
the production of purulent sputum, sometimes with blood 
streaking. 
Physical findings are of limited use in pulmonary 
tuberculosis. Many patients have no abnormalities detectable by 
chest examination, whereas others have detectable rales in the 
involved areas during inspiration, especially after coughing. 
Occasionally, rhonchi due to partial bronchial obstruction and 
classic amphoric breath sounds in areas with large cavities may 
be heard. Systemic features include fever (often low-grade and 
intermittent) in up to 80% of cases and wasting. 
Extrapulmonary tuberculosis:- 
 In order of frequency, the extrapulmonary sites most 
commonly involved in tuberculosis are the lymph nodes, pleura, 
genitourinary tract, bones and joints, meninges, peritoneum, and 
pericardium. However, virtually all organ systems may be 
affected. As a result of hematogenous dissemination in HIV- 
infected individuals, extrapulmonary tuberculosis is seen more 
commonly today than in the past.  
Diagnosis of tuberculosis:- 
 The key to the diagnosis of tuberculosis is a high index of 
suspicion.  
AFB Microscopy:- 
 A presumptive diagnosis is commonly based on the findings 
of AFB on microscopic examination of a diagnostic specimen, 
such as a smear of expectorated sputum or of tissue ( e.g., a 
lymph node biopsy). Although rapid and inexpensive, AFB 
microscopy has relatively low sensitivity (40-60%) in confirmed 
cases of pulmonary tuberculosis. Most modern laboratories 
processing large numbers of diagnostic specimens use auramine-
rhodamine staining and fluorescence microscopy. The more 
traditional method- light microscopy of specimens stained with 
Kinyoun or Ziehl-Neelsen basic fuchsin dyes-is satisfactory, 
although more time-consuming. For patients with suspected 
pulmonary tuberculosis, three sputum specimens, preferably 
collected early in the morning should be submitted to the 
laboratory for AFB smear and mycobacterial culture. 
Mycobacterial Culture:- 
 Definitive diagnosis depends on the isolation and 
identification of M.Tuberculosis from a clinical specimen or the 
identification of specific sequences of DNA in a nucleic acid 
amplification test (see below). Specimens may be inoculated onto 
egg- or agar- based medium (e.g., Lowenstein-Jensen or 
Middlebrook 7H10) and incubated at 37oc (under 5% CO2 for 
Middlebrook Medium). Because most species of mycobacteria, 
including M.Tuberculosis, grow slowly, 4-8 weeks may be 
required before growth is detected.  
Nucleic Acid Amplification:- 
 Several test systems based on amplification of 
mycobacterial nucleic acid are available. These systems permit 
the diagnosis of tuberculosis in as little as several hours, with 
high specificity and sensitivity approaching that of culture. 
Radiographic procedures:- 
 The initial suspicion of pulmonary tuberculosis is often 
based on abnormal chest radiographic findings in a patient with 
respiratory symptoms. Although the “classic” picture is that of 
upperlobe disease with infiltrates and cavities virtually any 
radiographic pattern-from a normal film or a solitary pulmonary 
nodule to diffuse alveolar infiltrates in a patient with ARDS-may 
be seen. In the era of AIDS, no radiographic pattern can be 
considered pathognomonic. CT may be useful in interpreting 
questionable findings on plain chest radiography and may be 
helpful in diagnosing some forms of extrapulmonary tuberculosis 
e.g., Pott’s disease. MRI is useful in the diagnosis of intracranial 
tuberculosis. 
 
 
 
 
 
Serologic and other diagnostic tests for active tuberculosis:- 
 Determination of ADA levels in pleural fluid may be useful 
in the diagnosis of pleural tubercolusis; the utility of this test in 
the diagnosis of other forms of extrapulmonary tuberculosis (e.g. 
pericardial, peritoneal, and meningeal) is less clear.  
Tuberculosis skin testing:-  
 In 1891, Robert Koch discovered that components of 
M.Tuberculosis in a concentrated liquid culture medium, 
subsequently named “old tuberculin” (OT),were capable of 
eliciting a skin reaction when injected subcutaneously into 
patients with tuberculosis. In 1932, Seibert and Munday purified 
this product by ammonium sulfate precipitation to produce an 
active protein fraction known as tuberculin purified Glenn, was 
chosen as the international standard. Later, the WHO and 
UNICEF sponsored large scale production of a master batch of 
PPD (RT23) and made it available for general use. The greatest 
limitation of PD is its lack of mycobacterial species specificity, a 
property due to the large number of proteins in this product that 
are highly conserved in the various species. In addition, 
subjectivity of the skin-reaction interpretation deterioration of the 
product, and batch-to-batch variations limit the usefulness of 
PPD. 
Skin testing with tubercuilin-PPD (TST) is most widely 
used in screening for latent M.Tuberculosis infection (LTBI). The 
test is of limited value in the diagnosis of active tuberculosis 
because of its relative of low sensitivity and specificity and its 
inability to discriminate between latent infection and active 
disease. 
IFN - Gamma Release Assays (IGRAs):- 
 Recently, two in vitro assays that measure T cell release of 
IFN-gamma in response to stimulation with the highly 
tuberculosis specific antigents ESAT-6 and CFP-10 have become 
commercially available. Quanti FERON-TB Gold® (cellestis 
Ltd., Carnegie, Australia) is a whole blood enzyme-linked 
immunosorbent assay (ELISA) for measurement of IFN-y and T-
SPOT.TB ® (Oxford Immunotec, Oxford, UK) is an enzyme-
linked immunospot (ELISpot) assay. IGRAs are more specific 
than the TST as a result of less Cross-reactivity due to BCG 
vaccination and sensitization by nontuberculous mycobacteria. 
IGRAs also appear to be at least as sensitive as the TST in active 
tuberculosis. 1 
Because of the high specificity and other potential 
advantages, IGRAs are likely to replace the TST for LTBI 
diagnosis in low-incidence, high-income settings where cross-
reactivity due to BCG might adversely impact the interpretation 
and utility of the TST. 
Treatment of Tuberculosis:- 
 The two aims of tuberculosis treatment are to interrupt 
tuberculosis transmission by rendering patients noninfectious and 
to prevent morbidity and death by curing patients with 
tuberculosis. 
 
 
 
Drugs:- 
 Four major drugs are, considered the first-line agents for the 
treatment of tuberculosis:isoniazid, rifampin, pyrazinamide, and 
ethambutol 
Because of a lower degree of efficacy and a higher degree 
of intolerability and toxicity, six classes of second-line drugs are 
generally used only for the treatment of patients with tuberculosis 
resistant to first line drugs. Included in this group are the 
injectable aminoglycosides streptomycin (formerly a first line 
agent), kanamycin, and amikacin; the injectable polypeptide 
capreomycin; the oral agents ethionamide, cycloserine, and PAS; 
and the fluoroquinolone antibiotics. Of the quinolones,  third 
generation agents are preferred; levofloxacin, gatifloxacin and 
moxifloxacin. 
 
 
 
 
HIV-ASSOCIATED TUBERCULOSIS 
 Tuberculosis is one of the most common diseases among 
HIV-infected persons worldwide. In some African countries, the 
rate of HIV infection among tuberculosis patients reaches 70-
80% in certain urban settings. A person with a positive TST who 
acquires HIV infection has a 3-13% annual risk of developing 
active tuberculosis. A new tuberculosis infection acquired by an 
HIV –infected individual may evolve to active disease in a matter 
of weeks rather than months or years. 1,2  
 Tuberculosis can appear at any stage of HIV infection, and 
its presentation varies with the stage. When CMI is only partially 
compromised, pulmonary tuberculosis presents in a typical 
manner,    with upper-lope infiltrates and cavitation and with out 
significant lymphadenopathy or pleural effusion. In late stages of 
HIV infection, a primary tuberculosis – like pattern, with diffuse 
interstitial or military infiltrates, little or no cavitation, and 
intrathoracic lymphadenopathy, is more common. Overall, 
sputum smears may be positives less frequently among 
tuberculosis patients with HIV infection than among those 
without; thus, the diagnosis of tuberculosis may be unusually 
difficult, especially in view of the variety of HIV-related 
pulmonary conditions mimicking tuberculosis. 
Extrapulmonary tuberculosis is common among HIV 
infected patients. In various series, extrapulmonary tuberculosis – 
alone or in association with pulmonary disease-has been 
documented in 40-60% of all cases in HIV-co-infected 
individuals. The most common forms are lymphatic, 
disseminated, pleural, and pericardial. Mycobacteremia and 
meningitis are also frequent, particularly in advanced HIV 
disease. 
The diagnosis of tuberculosis in HIV- infected patients may 
be difficult not only because of the increased frequency of 
sputum-smear negativity (upto 40% in culture-proven pulmonary 
cases) but also because of atypical radiographic findings, a lack 
of classic granuloma formation in the late stages, and a negative 
TST. 
 In general, the standard treatment regimens are equally 
efficacious in HIV-negative and HIV-positive patients. 
Three important considerations are relevant to tuberculosis 
treatment in HIV-infected patients. 
Immune Reconstitution inflammatory syndrome is more 
common among patients with advanced immunosuppression and 
extrapulmonary tuberculosis. 
Glucocorticoids have been used for more severe reactions, 
although their use in this setting has not been formally evaluated 
in clinical trials. 
Rifabutin, which has much less enzyme-inducing activity, 
has been recommended in place of rifampin. 
 
 
 
 
 
 
CHEST X RAY IN PULMONARY TUBERCULOSIS 
 A normal chest film almost, although not completely, 
excludes pulmonary tuberculosis.  There are two provisos.  First, 
it has been shown in a number of studies that small radiological 
lesions are easily missed.  Such observer error may be reduced by 
double reading by two independent observers or even by the 
same observer on two separate occasions.  Second, it is possible 
for a patient to have localized post primary endobronchial 
tuberculosis with a positive sputum and a normal chest film. 
Appearance suggestive of tuberculosis : 
 It is seldom possible to make a completely confident 
diagnosis of pulmonary tuberculosis on radiological grounds 
alone, as almost all the manifestations of tuberculosis can be 
mimicked by other diseases.  The following characteristics of a 
chest radiograph favour the diagnosis of tuberculosis. 2 
1. Opacities mainly in the upperzone 
2. Patchy or nodular opacities 
3. presence of a cavity or cavities 
4. Presence of calcification 
5. Bilateral opacities especially if in upper zones 
6. Opacities that persist after several weeks  
In appropriate areas, such as North America, all these 
appearances can be found in histoplasmosis and most of them in 
coccidioidomycosis. 
 Pulmonary tuberculosis can mimic almost all other 
pulmonary diseases in much the same way that syphilis mimic 
most neurological diseases. 
 Soft confluent shadows alone suggest an exudative process 
and may be difficult to distinguish initially from a simple 
pneumonia.  There may be different foci in the lungs.  Linear 
shadows especially if they produce distortion of fissures, trachea, 
mediastinum or diaphragm, suggest fibrosis.  Bilateral upper zone 
fibrotic shadows, with shrinkage of the upper lobes and elevation 
of the pulmonary hila, is a common picture.  The presence of 
calcification suggests healed disease, although activity is 
impossible to determine solely on radiographic grounds, in many 
cases reactivation occurring on a back ground of an old calcified 
lesion.  Linear and soft shadows may coexist.  Tuberculosis 
disease is usually located in the posterior or apical segments of 
the upperlobe but, exceptionally, may be restricted to the anterior 
segment of the upper lobe. 
 Cavitation results from a valvular process in a draining 
bronchus.  Cavities in a mass of caseous material may initially 
have irregular wall that later become smoother and thinner as 
caseous material is coughed up or absorbed.  A cavity may 
become ‘blocked’ and fill with purulent or caseous material, so 
called tuberculoma but with effective chemotherapy such lesions 
usually resolve satisfactorily.  However, cavities may persist 
permanently even after effective chemotherapy and eventually be 
colonized by Aspergillus to produce an Aspergilloma.  
Tuberculous cavities may be differentiated from non tuberculosis 
cavities on the basis of a longer history of illness and the 
presence around them and in other parts of the lungs of patchy or 
nodular infiltrates and atelectasis.  Non tuberculous cavities more 
often have putrid sputum, associated leucocytosis and fluid 
levels. CT may sometimes be used to confirm the presence of 
cavities and may also be useful in detecting calcification in a 
suspicious lesion ; this, and the presence of satellite lesions on 
such tomographic studies, make the diagnosis of tuberculosis 
more likely. 
 Bronchiectasis may be suggested by elongated translucent 
areas in the upper zones and can be confirmed by bronchography, 
although this does not affect management.  If such a bronchus 
become blocked and fills with caseous material, a so called 
bronchial cold abscess may form and show as a solid looking 
elongated dense shadow, sometimes scalloped. 
 Enlargement of hilar or paratracheal lymph nodes is unusual 
in European adults but more frequent in Asians or Africans.  The 
lymphadenopathy and pyrexia in the presence of a positive 
tuberculin test may be the only manifestations of tuberculous 
disease.  Tuberculosis limited to the lower zones of the lung is 
uncommon but does occur. 
Radiological classification of disease extent : 
 For clinical and research purposes the classification of the 
National Tuberculosis Association of the USA has proved useful. 
Minimal : 
 Minimal lesions include those that are of slight to moderate 
density but which do not contain demonstrable cavitation.  They 
may involve a small part of one or both lungs, but the total extent, 
regardless of distribution, should not exceed the volume of lung 
on one side that occupies the space above the second 
chondrosternal junction and the spine of the fourth or the body of 
the fifth thoracic vertebra. 
Moderately advanced : 
 Moderately advanced lesions may be present in one or both 
lungs, but the total extent should not exceed the following limits : 
disseminated lesions of slight to moderate density that may 
extend through out the total volume of one lung or the equivalent 
in both lungs ; dense and confluent lesions limited in extent to 
one third volume of one lung ; total diameter of cavitation, if 
present, must be less than 4 cm. 2 
Far advanced : 
 Lesions more extensive than moderately advanced. 
HIV ASSOCIATED PULMONARY TUBERCULOSIS AND 
CHEST X RAY 
 
 As many clinical and radiological manifestations of 
tuberculosis depends on an intact immune system, a deficient 
immune system as in HIV infection alters it.  The manifestations 
can be 
   1.   Progressive Primary pulmonary TB 
 Usually primary tuberculosis is a self limiting infections 
without much complication. But in HIV patient a progressive 
infection is common as immunity is deficient.  It can cause 
pleural effusion, miliary pattern, and bilateral hilar adenopathy. 
2. Post primary 
a. Hilar and mediastinal lymphadenopathy 
b. Bilateral pleural effusion 
c. Diffuse infilterates 
Lower Incidence of cavitary lesions  
 It is a well documented feature in many reviews. Dr. 
Aderaya et al13 reported lower incidence of cavitary disease in 
HIV positive individuals when compared to negative individuals 
in a clinical and epidemiological study. 
 Dr. Guilherme Freire Garcia et al4,6 reported that in HIV 
patients with CD4 count < 200 the incidence of cavitation was 
less than 7.4% when compared to HIV patients with CD4 count > 
200 – 54.5%.  This study proved that the level of immuno 
suppression has a binding with radiological profile. 
 Another study by David C. Perlman12 reported less 
incidence of cavitation in HIV positive individuals 50% versus 
79%. 
Isolated Lower zone infilterates : 
 HIV patients with tuberculosis is found to have more 
isolated lower zone infilterates in studies. 
Normal chest X ray 
 In a study by Dr. Aderaye13 Normal chest x ray was found 
in 9.2% of all the cases and was more common in HIV positive 
individuals. 
  
 Another study by Dr. Pepper T. Joseph10 showed 9% 
patients had normal chest x ray and 58.4% patients of them were 
HIV positive. 
 Another study by Dr. Guilherme Freire Garcia et al4 showed 
14.8% normal x ray in HIV positive compared to 9% in HIV 
negative pulmonary TB cases. 
 David C. Perlman12 showed no relation of CD4 count and 
normal chest x ray finding in HIV positive individuals. 
 HIV co-infection has got multi dimensional effect on 
various aspects of pulmonary tuberculosis ranging from 
incidence, and clinical features to investigations and 
management. 
 
 
 
 
 
 MATERIALS AND METHODS 
 The cases analysed in this study were patients who have 
registered under RNTCP programme in thoracic medicine 
department of Govt. Rajaji Hospital, Madurai after referral from 
various other departments. 
 After recording the presenting complaints, specific history 
of Diabetes mellitus, chronic kidney disease, immuno 
suppression therapy, and haematological malignancy is obtained.  
Patients with h/o any of the above conditions are excluded. As 
these condition can cause chest x ray pictures similar to HIV 
infection in pulmonary tuberculosis patients.   A complete 
physical examination is done. 
 Patients with positive sputum AFB results whose HIV 
status is already checked or who are willing to check are included 
in the study. 
 After obtaining the HIV status all the patients under went 
chest x ray evaluation except those patients who had a recent 
chest x ray after diagnosis of tuberculosis. 
Inclusion Criteria : 
1. Pulmonary tuberculosis proved by atleast one positive 
sputum AFB result. 
2. Presence of chest x ray taken immediately after diagnosis 
of tuberculosis. 
3. Known HIV status. 
4. Known CD4 count if HIV positive 
5. Consent 
Exclusion Criteria : 
 Any condition which can cause immuno suppression 
1. Diabetes mellitus 
2. Chronic kidney disease 
3. Immuno suppression therapy 
4. Hematological malignancy 
Patients who satisfied both criteria were selected for this study. 
  The chest x ray features are noted down for each patients.  
The features studied include pleural effusion, lung collapse, 
cavity, alveolar opacity in upper, middle and lower zones, 
interstitial shadowing, hilar lymphadenopathy, pleural thickening 
and normal chest x ray finding. 
 Those patients who are found to have HIV positivity would 
have undergone CD4 count estimation which is available at the 
ART centre in Government Rajaji Hospital.  The CD4 count also 
was noted down. 
 The chest x ray features were divided into two groups 
according to presence of atypical features.  So that all the chest x 
rays were either having typical or atypical features. 
Atypical chest x ray features includes 
1. Unilateral or bilateral lower zone infiltrates without 
affecting respective upper zone 
2. Bilateral pleural effusion 
3. Normal chest x ray  
4. Bilateral hilar or  mediastinal lymphadenopathy 
5. Interstitial shadowing 
After getting all the data the following comparisons were 
made between the two groups. 
1. Age distribution 
2. Male and female ratio 
3. Percentage of various chest x ray features 
4. Percentage of atypical features 
5. Percentage of atypical features with relation to CD4 
count 
 
 
 
 
 
 
 
 
RESULTS 
 Total number of patients studied - 60 
 HIV positive patients   - 26 
 HIV negative patients   - 34 
 
Table – 1 
Age Distribution 
Age in years HIV  Positive HIV Negative 
< 14 years 0 0 
15-29 years 6 6 
30-44 years 13 12 
45-59 years 7 11 
> 60 years 0 5 
Total 26 34 
 
 Mean age of HIV positive patients -  37.54 + 10.21 
 Mean age of HIV negative patients - 42.26 + 12.87 
  
 Table – 2 
Sex Distribution 
Pulmonary TB cases  
Sex HIV  Positive HIV Negative 
Male 18 25 
Female 8 9 
Total 26 34 
 
P value   -  0.631   Not significant 
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Table – 3 
Various chest x ray features 
 
 Positive % Negative % P value 
Pleural effusion 5 19.2 3 8.8 0.247 
Collapse 0 0 0 0  
Cavity 3 11.5 13 38.23 0.016 
Upper zone 14 53.8 29 85.29 0.024 
Middle zone 0 0 3 8.8 0.13 
Lower zone 8 30.7 1 2.9 0.0023 
Interstitial 1 3.8 0 0 0.256 
Hilar 
adenopathy 
0 0 0 0  
Pleural 
thickening 
0 0 0 0  
Normal 7 26.9 4 11.76 0.137 
 
HIV positive patients had significantly higher incidence of  
lower zone infiltrates and lower incidence of cavity and upper 
zone infiltrates. 
 
Table - 4 
Atypical Chest X ray  
 
 HIV positive HIV Negative 
 No.of 
patients 
% No.of 
patients 
% 
Present 16 61.5 5 14.8 
Absent 10 38.5 29 85.2 
Total 26  34  
 
 P value  -   0.0001  -  very significant 
 HIV positive patients had significantly higher incidence of 
atypical features on chest x ray than HIV negative patients. 
 
 
 
 
 
 
 
ATYPICAL CHEST X RAY
16
61.5
5
14.8
10
38.5
29
85.2
0
10
20
30
40
50
60
70
80
90
No.of patients % No.of patients %
HIV positive HIV Negative
Present Absent
 
Table - 5 
Atypical Chest X ray  & CD4 count 
CD4 count No.of cases Atypical 
features 
Percentage 
        <  100 8 8 100 % 
     101 – 199 10 7 70% 
        >  200 8 1 12.5% 
 
 Lower CD4 count patients had higher incidence of atypical 
features on chest x ray. 
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DISCUSSION 
 In this study, out of the total 60 patients, 26 were HIV 
positive and 34 were HIV negative. 
 The mean age of HIV positive patients was 37 yrs and HIV 
negative patients was 42 years.  This may indicate that the HIV 
positive individuals contract tuberculosis infection early. Usually 
tuberculosis reactivation occurs as the age progresses and 
immunity declines.  But in HIV positive individuals immunity 
declines early and may cause disease at an earlier age.  No patient 
was there in less than 14 years group. It is interesting to note that 
no HIV positive patient was there above the age of 60 years.  
This may be due to early death of HIV positive patients or due to 
the less risky behaviour of older persons compared to young 
adults. 
 The sex distribution of HIV positive and negative patients 
was equal as the p value was found to be 0.631 which indicates 
there was no significant difference in the two groups. 
 In this study there were no patient with collapse, Hilar 
adenopathy and pleural thickening in both groups. 
 Pleural effusion was found in 19.2% HIV positive patients 
and 8.8% in HIV negative patients.  The p value of 0.247 
indicates that the difference is not significant.  A study by         
Dr. Guilherme Freire Garcia et al4 indicated that pleural effusion 
was more common in HIV positive individual patients but there 
was no correlation between CD4 count and effusion. 
 Cavity was seen in 11.5% patients in HIV positive and 
38.23% of patients in HIV negative individuals with a p value of 
0.016 which signifies the finding.  As noted before many studies 
found out lower incidence of cavities in HIV positive individuals.  
There is a correlation between CD4 count and cavity as shown in 
the study by Dr. Guilherme Freire Garcia et al.4,6  As cavity 
formation occurs when the caseous material is couphed out. The 
process requires a good immune function when compared to 
other findings.  Caseous necrosis is the final product of the 
granulomatous reaction caused by, lymphoid cells, epitheloid 
cells and giant cells.  As in HIV positive patients the cell 
mediated immunity is blunted more so in those having lower 
CD4 count, the finding of lower incidence of cavity can be 
explained.  AL Pozniak et al9 also showed lower incidence of 
cavity in HIV positive patients. 
 
 Upper zone infiltrates was found in 53.8% of HIV positive 
patients and 85.29% of HIV negative patients with a p value of 
0.024.  It is a finding of classical pulmonary tuberculosis as the 
bacilli can survive better  in more oxygenated apical and 
posterior segment of upper lobe.  Another reason quoted for 
upper lobe infilterates in pulmonary tuberculosis include the 
lower blood circulation and less immune activity.  But in HIV 
positive patients as the cell mediated immunity is less the 
survival pressure of bacilli is less and the better blood supply of 
lower zones will not give a better immunity.  The study by Dr. 
Guilherme Freire Garcia et al4,8 showed that 64% of patients with 
CD4 count > 200 and none of the patients with CD4 count < 200 
had upper zone infiltrates.  This indicates that in pulmonary TB 
cases restriction of infiltrates to upper lobes is a function of cell 
mediated immunity. 
 Middle zone infiltrate were seen in none of the patients in 
HIV positive group and 8.8% of the HIV negative patients 
showed middle lobe involvement.  The p value of 0.13 indicates 
that finding is not significant. 
 Lower zone infiltrates were seen in 30.7% of HIV positive 
patients and 2.9% in HIV negative patients with a p value of 
0.0023 which showed very significant result.  Diffuse infiltration 
were found in many studies.  In the study by Dr. Guilherme 
Freire Garcia et al4,7 9.1% of patients with  CD4 count > 200 and 
37% of patients with CD4 count < 200 had diffuse infiltrates 
involving lower zones.  It may be due to the inability of the 
immune system in HIV positive patients to contain the infection 
to upper lobes. 
 Normal chest x ray was found in 26.9% of patients with 
HIV and 11.76% of patients without HIV.  The finding was not 
significant as indicated by the p value of .137.  This finding was 
found significant in many other studies.  Dr. Aderaya et al13,6 
showed that 9.2% of patients had normal chest x ray and it was 
more common in HIV positive individuals with a p value of 0.05.  
Dr. Gream berg et al in 1994 reported that Normal chest x rays 
are more common when CD4 count is less than 200 (21%) when 
compared to CD4 count > 200 (5%). 
 In 2008 Pepper T. Joseph10 reported that normal chest x ray 
in HIV positive patients was more likely if associated with renal 
failure. (p-0.048). 
 Atypical chest x rays were found in 21 patients. Out of that 
16 patients (76%) were HIV positive and 5 patients (24%) were 
HIV negative.  All the above studies quoted indicated higher 
incidence of atypical features in HIV positive individuals due to 
immuno suppression and decreased granuloma formation. 
 Among the HIV positive patients, atypical features are more 
common in patients with lower CD4 count.  Patients with CD4 
count less than 100 showed 100% presence of atypical features 
and patients with CD4 count between 100 and 200 showed 70% 
incidence of atypical features. Patients with CD4 count > 200 had 
only 12.5% incidence of atypical features. 
 These data confirm that the atypical features are due to 
immuno suppression and the more the immune suppression the 
more the atypical features in chest x ray. 
 
 
 
 
 
 
 
 
 
 
 
 
SUMMARY 
¾ The aims of study were stated 
¾ Literature on Tuberculous, HIV and tuberculosis co-
infection, chest x ray of TB and chest  x ray of HIV and TB 
co-infection was reviewed. 
¾ Materials and methods of the study were stated. 
¾ Analysis of data was done. 
 Total number of patients were  60 
  HIV positive patients were  26 
  HIV negative patients were 34 
¾ HIV positive patients had significantly higher incidence of 
lower zone infiltration. 
¾ HIV positive patients had significantly lower incidence of 
cavities and upper zone infiltrates. 
¾ Normal chest x rays are found in higher proportion of HIV 
positive individual but was found to be not significant. 
¾ HIV positive patients had significantly higher incidence of 
atypical features on chest x ray than HIV negative patients. 
¾ Atypical features on chest x ray correlates with CD4 count 
as lower CD4 count patients had higher incidence of 
atypical features on chest x ray. 
 From the discussion it was inferred that HIV co-infection is 
associated with higher incidence of atypical features.  Atypical 
features found in this study included higher incidence of lower 
zone infiltrates and lower incidence of upper zone infiltrates and 
cavity.  Atypical features occurred more frequently with lower 
CD4 count. 
 The diagnosis of pulmonary tuberculosis in HIV infected 
patients are difficult as the clinical and investigational evidences 
are altered especially chest radiography. 
 
 
 
 
 
 
  
CONCLUSION 
 
 There is a significant relationship between HIV co-infection 
and chest radiography in pulmonary tuberculosis. 
 
 Atypical chest radiography is significantly higher in HIV 
co-infected patients with pulmonary tuberculosis. 
 
 Atypical chest radiographic findings are more common in 
patients with lower CD4 counts. 
 
 These findings emphasize the use of various investigations 
together with clinical features for the accurate diagnosis of 
pulmonary tuberculosis in patients with HIV co-infection. 
 
 
 
 
 
BIBLIOGRAPHY 
1. Harrison’s Text book of Principles of Internal Medicine, 
17th edition. 
 
2. Crofton & Douglas’s Respiratory diseases, 5th edition. 
 
3. Park’s Text book of Preventive and social medicine, 19th 
edition. 
 
4. Guilherme Freire Garcia; Alexandre Sampaio 
Moura; Cid Sérgio Ferreira; Manoel Otávio da 
Costa Rocha Rev. Soc. Bras. Med. 
Trop. vol.40 no.6 Uberaba Nov./Dec. 2007. 
 
5. Atul Shah, PP Mehrotra, HlDhar Statistician ; Medical 
Records Officer; Director Research, Bombay Hospital 
Trust, Mumbai - 20. 
 
6. Ho, T T; Wong, K H; Lee, S S.Int J STD AIDS. 1999 
Jun;10(6):409-12.  
 
7. Stephen D. Greenberg, MD {149} David Frager, MD 
{149} Bernard Suster, MD {149} Sidney Walker, MD. 
  
8. Christine Stavropoubos, MD {149} Allen Rothpearl, MD.  
Radiology 1994; 193:115-119. 
 
9. AL Pozniak et al LucÈlia Henn+, Fabiano Nagel, Felipe 
Dal Pizzol, Mem Inst Oswaldo Cruz, Rio de Janeiro, Vol. 
94(3): 377-381, May/Jun. 1999. 
 
10. Dr. Pepper T. Joseph О. М. Leonenko et al, CHEST 
X:RAY PECULIARITIES OF PULMONARY 
TUBERCULOSIS IN HIV:INFECTED SUBJECTS AND 
AIDS PATIENTS, 7th edition, pg 456-487 
 
11. P.O. Awil, S.J. Bowlin, T.M. Daniel Eur Respir J 1997; 
10: 615–618, DOI: 10.1183/09031936.97.10030615, 
European Respiratory Journal, ISSN 0903 - 1936 
 
12. David C. Perlman et al, Clinical Infectious Diseases 
1997;25:242–6 1997 by The University of Chicago. All 
rights reserved, 1058–4838/97. 
 
13. Aderaya et al, Chest X ray in HIV positive tuberculosis in 
Ghana, African Journal of Respiratory medicine. Vol. 19, 
page 222- 240. 
 
PROFORMA 
Name  :      Date : 
Age   :      Sex   : 
Address  :      IP/OP No. : 
 
Complaints : 
History : 
 Cough 
 Sputum 
 Haemoptysis 
 Weight loss 
 Fever 
Examination : 
 Oral candidiasis 
 Oral hairy leukoplakia 
 Pulse rate 
 Blood pressure 
CVS 
RS 
Abdomen 
CNS 
Investigations : 
 Blood sugar 
 Urea 
 Creatinine 
 
Sputum AFB :       CD4 count 
HIV status     :     
CXR Features:     Right  Left 
 Pleural effusion 
 Lung collapse 
 Cavity 
     Upper zone 
 Alveolar opacity   Middle zone 
     Lower zone 
 Interstitial shadowing 
 Hilar lymphadenopathy 
 Pleural thickening 
 Normal chest x ray. 
 
 Atypical chest x ray finding 
 
 
 
 
 
 
 
 
 
 
RIGHT UPPER LOBE CAVITY 
(HIV NEGATIVE) 
 
 
 
 
 
 
 
 
 
     DIFFUSE BILATERAL DISEASE  
(HIV POSTIVE) 
 
 
 
 
 
 
 
  
 
 
MASTER CHART   (HIV Negative patients) 
Alveolar infiltrates S.No. Age Sex Atypical 
CXR 
Pleural 
effusion 
Collapse Cavity 
Upper 
zone 
Middle 
zone 
Lower 
zone 
Interstitial 
shadowing 
Hilar 
Adenopathy
Normal 
CXR 
1. 44 F -   + +      
2. 40 M +         + 
3. 32 M -   + +      
4. 42 M -    +      
5. 54 M - +  + +      
6. 29 F -    +      
7. 48 M +         + 
8. 28 F - +   +      
9. 45 F -   + +      
10. 33 M -    +      
11. 30 M -   + +      
12. 18 F -   + +      
13. 37 M -    +      
14. 45 M -   + +      
15. 37 M -   + +      
16. 40 M -    +      
17. 58 M -   + +      
18. 65 M -    +      
19. 15 F -    +      
20. 46 M -    +      
21. 51 M -    +      
22. 60 M -    + +     
23. 60 M -    +      
24. 60 M -    +      
25. 46 F +      +    
26. 25 M -    + +     
27. 54 F +         + 
28. 39 M -    +      
29. 42 M -    + +     
30. 31 M -    +      
31. 28 M -   + +      
32. 61 F +         + 
33. 55 M -    +      
34. 36 M -    +      
 
MASTER CHART   (HIV Positive patients) 
Alveolar infiltrates S.No. Age Sex CD4 
count 
Atypical 
CXR 
Pleural 
effusion
Collapse Cavity
Upper 
zone 
Middle 
zone 
Lower 
zone 
Interstitial 
shadowing
Hilar 
Adenopathy
Normal 
CXR 
1.  43 M 242 -    +      
2.  21 F 124 +         + 
3.  30 M 84 +    +  +    
4.  40 M 94 +         + 
5.  37 M 398 -    +      
6.  35 F 124 + +         
7.  55 M 196 -    +      
8.  28 F 98 +         + 
9.  32 M 118 +    +  +    
10. 55 F 87 + +         
11. 29 M 136 - +   +     + 
12. 45 M 126 +          
13. 58 M 242 -    +     + 
14. 47 F 178 + +   +      
15. 35 M 116 +          
16. 28 M 246 +   + +  +    
17. 30 M 86 +          
18. 37 M 126 -    +  +    
19. 30 F 386 -   + +      
20. 49 M 214 -   + +      
21. 54 M 256 -    +  +    
22. 38 M 98 +      +    
23. 32 F 79 +      + +   
24. 33 M 264 -    +      
25. 28 F 76 +         + 
26. 27 M 126 + +     +    
 
